Skip to content

AcrySof™ IQ Vivity™ DFT415 (REF DFT415.180)Recalls & reported problems

Alcon Laboratories, Inc. · Sterile UV and Blue Light Filtering Acrylic Foldable Aspheric Wavefront-Shaping Toric Posterior Chamber Intraocular Lenses · Class 3 · Implant

Adverse event reports
2
Deaths reported
0
Injuries reported
1
Recalls naming it
0

Summary

The FDA's MAUDE database contains 2 adverse event reports that list this exact device (DI 00380652422017), received between Feb 24, 2025 and Mar 3, 2026 — classified as 1 injury, 1 malfunction.

The most frequently reported specific device problem is “Material Opacification” (1 report).

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. How this data works · Data updated Oct 13, 2026.

Reports received per month

Nov 2023: 0 reportsDec 2023: 0 reportsJan 2024: 0 reportsFeb 2024: 0 reportsMar 2024: 0 reportsApr 2024: 0 reportsMay 2024: 0 reportsJun 2024: 0 reportsJul 2024: 0 reportsAug 2024: 0 reportsSep 2024: 0 reportsOct 2024: 0 reportsNov 2024: 0 reportsDec 2024: 0 reportsJan 2025: 0 reportsFeb 2025: 1 reportsMar 2025: 0 reportsApr 2025: 0 reportsMay 2025: 0 reportsJun 2025: 0 reportsJul 2025: 0 reportsAug 2025: 0 reportsSep 2025: 0 reportsOct 2025: 0 reportsNov 2025: 0 reportsDec 2025: 0 reportsJan 2026: 0 reportsFeb 2026: 0 reportsMar 2026: 1 reportsApr 2026: 0 reportsMay 2026: 0 reportsJun 2026: 0 reportsJul 2026: 0 reportsAug 2026: 0 reportsSep 2026: 0 reportsOct 2026: 0 reports2024202520261
Last 36 months. The most recent month may be incomplete.

Most reported problems

Device problems

  • Material Opacification1
  • Product Quality Problem1

Patient problems

  • Insufficient Information1
  • Visual Impairment1

Recent adverse event reports

The 2 most recent of 2 reports, in the reporter's own words as published by the FDA.

  • MalfunctionMar 3, 2026Product Quality Problem

    A NON-HEALTHCARE PROFESSIONAL REPORTED THAT DURING AN INTRAOCULAR LENS (IOL) IMPLANT PROCEDURE, THE LENS HAD BEEN FAULTY AND COULD NOT BE USED. ADDITIONAL INFORMATION HAS BEEN REQUESTED.

    Patient problems: Insufficient Information

    MAUDE report 24496305 ↗
  • InjuryFeb 24, 2025Material Opacification; Material Opacification

    A PHYSICIAN REPORTED THAT FOLLOWING AN INTRAOCULAR LENS (IOL) IMPLANT PROCEDURE, COMPANY IOL WAS IMPLANTED IN BOTH EYES. POST-OPERATIVE UNCORRECTED VISUAL ACUITY WAS RECORDED AS 0.9 IN THE RIGHT EYE AND 0.8 IN THE LEFT EYE. PATIENT WAS EXPERIENCING IMPAIRED VISION IN THE LEFT EYE, DESCRIBING A DISTINCT CLOUDING THAT IMPROVES SLIGHTLY WHEN LOOKING PAST IT, CAUSING A TILTED HEAD POSITION. THE RIGHT EYE REMAINS UNAFFECTED. UPON CONDUCTING A SLIT LAMP EXAMINATION, THE SURGEON OBSERVED A VERTICAL, EXTENSIVE CLOUDING ON THE LENS OF THE LEFT EYE, APPROXIMATELY 1.5 MM WIDE AND 5 MM LONG, LIKELY ON THE FRONT OF THE IOL. LENS REMAINS IMPLANTED IN THE PATIENT'S EYE. ADDITIONAL INFORMATION WAS REQUESTED.

    Patient problems: Visual Impairment

    MAUDE report 21447560 ↗

Other Extended depth of focus intraocular lens devices

All Extended depth of focus intraocular lens devices →

Sources: FDA GUDID, MAUDE and Medical Device Recalls via openFDA. openFDA data is not validated for clinical or regulatory use.